Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP155789.RACy6sgzudELA1Ml6aUv-KxSE_LF7wxFbIFEUE-K5sPQk130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155789.RACy6sgzudELA1Ml6aUv-KxSE_LF7wxFbIFEUE-K5sPQk130_provenance.
• NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465341.RA8ZRlIBDK88O9ffb6724rqjQTw-Xu6nJJfJ1V8LLYi3w130_provenance.
• NP629210.RASBXrTWmlUq9E3Nk71vy3ur9rKsgQQIXxuwjDuM2b1r4130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629210.RASBXrTWmlUq9E3Nk71vy3ur9rKsgQQIXxuwjDuM2b1r4130_provenance.
• NP761117.RAS644lCXN1j-ceh0b9A6KL2KHFYSzWffPp3HeRz_4eao130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761117.RAS644lCXN1j-ceh0b9A6KL2KHFYSzWffPp3HeRz_4eao130_provenance.
• NP396046.RAyp-1crgHz9jStuHC4ie-bEDZ3kgCT63WZhoFCoTdTZE130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396046.RAyp-1crgHz9jStuHC4ie-bEDZ3kgCT63WZhoFCoTdTZE130_provenance.
• NP572029.RA1QnQ-AtrgymZkloXnJi18t9F69MJqVEUlpnSxlFJIxE130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572029.RA1QnQ-AtrgymZkloXnJi18t9F69MJqVEUlpnSxlFJIxE130_provenance.
• assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728241.RAjMf7cifejCpWVvjbgYyChpdZDNcofQzeC4eYigT0rR4130_provenance.
• NP728242.RAk9HzZNHPzVt90BNuePi6ooY4eM1QcQlcnNd3qCZkrM8130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728242.RAk9HzZNHPzVt90BNuePi6ooY4eM1QcQlcnNd3qCZkrM8130_provenance.
• NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833452.RAI6R1Qn0A0B2SBI-4MlkFL1pgxFTzrluKfNyLoBzF2Eg130_provenance.
• NP230875.RAJsBpqlg2oqkyIHX53d6YaOR3_4ggXkvOal-Ohau7ZHQ130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230875.RAJsBpqlg2oqkyIHX53d6YaOR3_4ggXkvOal-Ohau7ZHQ130_provenance.
• NP728246.RA40BMq8TldSAyU7mVTOsora0Lp-dmjNAPCLqdNXTjqBM130_assertion description "[To investigate whether human angiotensinogen protects against tumor progression in vivo, we established an original bitransgenic model in which transgenic mice expressing human angiotensinogen (Hu-AGT-TG mice) were crossed with a transgenic mouse model of hepatocellular carcinoma (HCC-TG mice).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728246.RA40BMq8TldSAyU7mVTOsora0Lp-dmjNAPCLqdNXTjqBM130_provenance.